Amendment 250 to article 16, after paragraph 2
Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest
A10-0272/2025 – Tomislav Sokol – Article 16, after § 2 – Am 250
Rejected
- For
- 141
- Against
- 516
- Abstained
- 7
roll-call vote at 12:47 · 21% of votes cast in favour
Roll call requested by The Left
How the groups voted
A group’s line is the position at least two thirds of its voting MEPs took; otherwise it is shown as Divided. Groups from left to right.
| Group | For | Against | Abstained | of | Line |
|---|---|---|---|---|---|
| The Left | 39 | 0 | 0 | 39 | For |
| Greens | 51 | 0 | 0 | 51 | For |
| S&D | 32 | 91 | 2 | 125 | Against |
| Renew | 1 | 66 | 1 | 68 | Against |
| EPP | 1 | 181 | 0 | 182 | Against |
| ECR | 0 | 70 | 1 | 71 | Against |
| Patriots | 0 | 78 | 0 | 78 | Against |
| ESN | 0 | 23 | 1 | 24 | Against |
| No group | 17 | 7 | 2 | 26 | — |
“of” = MEPs of the group who voted. Groups as they are now.
Every MEP
664 MEPs voted. Open a group, or filter above.
The Left 39 MEPs
Greens 51 MEPs
S&D 125 MEPs
Renew 68 MEPs
EPP 182 MEPs
ECR 71 MEPs
Patriots 78 MEPs
ESN 24 MEPs
No group 26 MEPs
“Votes in which an MEP voted differently from their group: on decision pages, against a line at least two thirds of the group took; in loyalty figures, against the position most of the group took.” = voted otherwise than a clear line (two thirds of its votes) of the group they sit in now. MEPs with no vote recorded are not listed.